Frequently Asked Questions
-
Do l need to have an existing business to apply?
Yes, you must have a UK registered business (you will need to provide a company registration number). The company should be fully committed to driving the venture forward and to making the most of the accelerator support package or have a product/service which is at TRL 3 and above. You will be required to explain how you meet the TRL level. TRL guidance below
TRL1
Technology’s Basic Principles Report
1. Lowest level of technology readiness;
2. Theoretical explanation on technology’s basic principles;
3. Initial survey on the benefits of the technology;
4.Basic concept review of scientific theories underlying the related medical device technology;
5. Formulation of basic concept and theoretical substantiation; and
6. Scientific literature review in relation to the technology’s basic principles.
TRL2
Technology Concept Formulation
1. Formulation of research topics, preparing hypotheses, and planning of experimental design to find the solution to problems on the basis of the technology concerned;
2. Preparation of scientific hypotheses. Research and protocol planning have been reviewed and approved; and
3. Through literature review and scientific discussions,
a research and study plan
is prepared to identify the potential and opportunity for therapeutic targets. Documented in the form of protocol or research plan to be reviewed and approved.
TRL3
Research to substantiate the technology concept (Research of Technology Concept).
1. Basic research, experimental data collection and analysis, to test the prepared hypotheses. Checking for alternative concepts, and identify and evaluate the technology’s components;
2. Initial testing on the design concept and evaluation of various alternatives;
3. Design verification, component specification determination;
4. Initial proof of concept of limited medical device’s technology and laboratory models; and
5. Documentation of results of laboratory-scale experiments providing initial proof of concept of the medical device’s technology.
TRL4
Laboratory-scale validation of components and/or sets of system (validation component in laboratory).
1. Laboratory-scale experiment and testing to evaluate and review the level of safety, side effects, and efficacy;
2. Preparation of procedures and methods to be used in a non-clinical and clinical studies;
3. Proof of concept of the technology and safety level; and
4. Publication (peer-reviewed) of data about proof of concept of the technology and safety level.
TRL5
Laboratory-Scale Prototype.
1. Designation of classification
(class 1, 2, or 3) of the medical device prototype based on
its equivalence with existing medical devices;
2. Lab-scale testing of prototype’s safety level against the applicable standard (for example: iec60601);
3. Lab-scale validation testing on prototype’s efficacy and side effects, and its disruption to/by other devices. (for medical device classes 1-2); and
4. Lab-scale substantiation of prototype’s safety level and efficacy.
TRL6
Industrial Scale Prototype.
1. Industrial-scale limited validation testing of the prototype on its efficacy and side effects, and its disruption to/by other devices. (for medical device classes 1-2);
2. Industrial-scale limited phase 1 clinical testing of the prototype to find out its safety level and efficacy (for medical device class 3); and
3. Industrial-scale limited substantiation of the prototype’s safety level and efficacy.
Source- annex_2_technology_readiness_level_trl_033020_final.pdf (britishcouncil.id)
-
What happens once I submit an Expression of Interest (EOI)?
Your EOI will be reviewed to ensure your company meets the eligibility criteria. Eligible EOIs will then sent an application form to complete.
-
How will my application be assessed?
A panel will independently assess each individual application against the selection criteria listed (see below). Scores from all panel members will be added up to generate an average scoring for each applicant across all criteria. Each criterion will be weighed equally, and shortlisted companies will be contacted for a brief interview and presentation.
-
What are the selection scoring criteria?
- Strength and relevance of proposed project: The application clearly articulates the product/service/material/technology that the company is looking to develop, what it’s USP is, and what is the challenge it is looking to address.
- Market awareness: The application has clearly identified a target market for commercialisation of the proposed product/service/material/technology, and it clearly demonstrates that some preliminary research into the relevant marketplace has been carried out.
- Innovation/Novelty: The application proposes a novel product/service/material/technology and/or business model.
- Viability and feasibility: The application has identified clear objectives and milestones for implementation of the proposed venture, and these are realisable within the parameters of the six-months programme, the available funding, and expertise.
- Programme fit: The application clearly articulates how the support package provided by the Healthcare Technologies Capabilities Connector SME Accelerator would be beneficial for the development of the proposed venture. Additionally, the knowledge gap and R&D needs identified by the proposed venture need to be a good match for the expertise available.
-
How much does it cost?
The company will need to show 20% match or in kind contribution, this can be costs spend for patent searches/IP costs, consumable costs, capital expenses for the project etc.
-
What will be the format of the programme?
There will be a mixture of in-person and online meetings and events including workshops taking place where your attendance will be mandatory. All the key dates will be provided at the start of the programme to ensure everyone is able to make the arrangements to attend them. Please note that attendance to the Showcase event in April 2025 is also mandatory.
-
What is the eligibility criteria?
Core (‘must have’) criteria:
- UK-based SME*, registered in Companies House
- Innovative new product/service/technology with the potential to scale-up and generate positive societal impact within the healthcare sector. Innovative product/service needs to be at TRL 3 or above to be part of the programme.
*An SME is defined as a company-
- employ fewer than 250 employees worldwide (including partners and executive directors), and
- has either an annual turnover not exceeding 50m euros, or an annual balance sheet total not exceeding 43m euros, and
- conforms to the following independence criteria:
An enterprise is considered independent unless 25% or more of the capital or of the voting rights is owned by an enterprise falling outside the definition of an SME whichever may apply, or jointly by several such enterprises. (This ceiling may be exceeded if the enterprise is held by public investment corporations, venture capital companies or organisational investors, provided no control is exercised either individually or jointly, or if the capital is spread in such a way that it is not possible to determine by whom it is held).
Desirable criteria:
Team of at least two entrepreneurs fully committed to making the most of the six-months accelerator programme and support package, including attending regular virtual meetings and occasional in-person activities and/or at least TRL 5 product/service.
-
Still have some questions?
Please email HTCC@herts.ac.uk